Xiaomeng Wang

Can the dual-functional capability of CIK cells be used to improve antitumor effects?

Hui Li, X. Ren, Wenwen Yu, 2014, Cellular immunology.

Amino Acid Metabolism Related to Immune Tolerance by MDSCs

X. Ren, Xiaomeng Wang, Bao-hong Yang, 2012, International reviews of immunology.

Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification

Xiaomeng Wang, S. Cao, Weijiao Du, 2021, Clinical case reports.

An Analysis of Clinical and Pathological Characteristics of 14431 Cases of Thyroid Carcinoma

J M Cao, Xiaomeng Wang, S. Cao, 2022, International Journal of Surgery: Oncology.

Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement

B. Meng, Xiaomeng Wang, S. Cao, 2023, Clinical case reports.